Fecal Calprotectin
The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global Burden of Disease Cancer Collaboration, Fitzmaurice, C., Allen, C., Barber, R. M., Barregard, L., Bhutta, Z. A., Brenner, H., Dicker, D. J., Chimed-Orchir, O., Dandona, R., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.5688 · Cited by 6,215
Molodecky, N. A., Soon, I. S., Rabi, D. M., Ghali, W. A., Ferris, M., Chernoff, G., Benchimol, E. I., Panaccione, R., Ghosh, S., Barkema, H. W., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.10.001 · Cited by 4,833
Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis
Lovell, R. M., & Ford, A. C. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.02.029 · Cited by 2,155
Inflammatory bowel disease: cause and immunobiology
Baumgart, D. C., & Carding, S. R. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60750-8 · Cited by 2,147
Rome IV—Functional GI Disorders: Disorders of Gut-Brain Interaction
Drossman, D. A., & Hasler, W. L. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.03.035 · Cited by 1,928
Predictability of the postoperative course of Crohn's disease
Rutgeerts, P., Geboes, K., Vantrappen, G., Beyls, J., Kerremans, R., & Hiele, M. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90613-6 · Cited by 1,820
Daperno, M., D'Haens, G., Van Assche, G., Baert, F., Bulois, P., Maunoury, V., Sostegni, R., Rocca, R., Pera, A., Gevers, A., et al. (2004) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(04)01878-4 · Cited by 1,774
A soluble protein characteristic of the nervous system
Moore, B. W. (1965) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(65)90320-7 · Cited by 1,695
Vogl, T., Tenbrock, K., Ludwig, S., Leukert, N., Ehrhardt, C., van Zoelen, M. A. D., Nacken, W., Foell, D., van der Poll, T., Sorg, C., et al. (2007) · Nature Medicine · doi:10.1038/nm1638 · Cited by 1,418
D’Haens, G., Sandborn, W. J., Feagan, B. G., Geboes, K., Hanauer, S. B., Irvine, E. J., Lémann, M., Marteau, P., Rutgeerts, P., Schölmerich, J., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.12.038 · Cited by 1,207
Colonoscopy versus Fecal Immunochemical Testing in Colorectal-Cancer Screening
Quintero, E., Castells, A., Bujanda, L., Cubiella, J., Salas, D., Lanas, Á., Andreu, M., Carballo, F., Morillas, J. D., Hernández, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1108895 · Cited by 916
Frolkis, A. D., Dykeman, J., Negrón, M. E., deBruyn, J., Jette, N., Fiest, K. M., Frolkis, T., Barkema, H. W., Rioux, K. P., Panaccione, R., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.07.041 · Cited by 892
Tibble, J. A., Sigthorsson, G., Bridger, S., Fagerhol, M. K., & Bjarnason, I. (2000) · Gastroenterology · doi:10.1053/gast.2000.8523 · Cited by 759
van Rheenen, P. F., Van de Vijver, E., & Fidler, V. (2010) · BMJ · doi:10.1136/bmj.c3369 · Cited by 714
Assessment of the Neutrophil Dominating Protein Calprotectin in Feces: A Methodologic Study
RØseth, A. G., Fagerhol, M. K., Aadland, E., & Schjønsby, H. (1992) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529209011186 · Cited by 669
Louis, E., Mary, J., Vernier–Massouille, G., Grimaud, J., Bouhnik, Y., Laharie, D., Dupas, J., Pillant, H., Picon, L., Veyrac, M., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.09.034 · Cited by 597
Costa, F., Mumolo, M. G., Ceccarelli, L., Bellini, M., Romano, M. R., Sterpi, C., Ricchiuti, A., Marchi, S., & Bottai, M. (2005) · Gut · doi:10.1136/gut.2004.043406 · Cited by 550
Peyrin-Biroulet, L., Reinisch, W., Colombel, J.-F., Mantzaris, G. J., Kornbluth, A., Diamond, R., Rutgeerts, P., Tang, L. K., Cornillie, F. J., & Sandborn, W. J. (2014) · Gut · doi:10.1136/gutjnl-2013-304984 · Cited by 502
A Quantitative Analysis of NSAID-Induced Small Bowel Pathology by Capsule Enteroscopy
Maiden, L., Thjodleifsson, B., Theodors, A., Gonzalez, J., & Bjarnason, I. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.020 · Cited by 499
A simple method for assessing intestinal inflammation in Crohn's disease
Tibble, J., Teahon, K., Thjodleifsson, B., Roseth, A., Sigthorsson, G., Bridger, S., Foster, R., Sherwood, R., Fagerhol, M., & Bjarnason, I. (2000) · Gut · doi:10.1136/gut.47.4.506 · Cited by 492
Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease
Konikoff, M. R., & Denson, L. A. (2006) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200606000-00013 · Cited by 453
Kehl-Fie, T. E., Chitayat, S., Hood, M. I., Damo, S., Restrepo, N., Garcia, C., Munro, K. A., Chazin, W. J., & Skaar, E. P. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2011.07.004 · Cited by 419
Diagnostic Precision of Fecal Calprotectin for Inflammatory Bowel Disease and Colorectal Malignancy
von Roon, A. C., Karamountzos, L., Purkayastha, S., Reese, G. E., Darzi, A. W., Teare, J. P., Paraskeva, P., & Tekkis, P. P. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01126.x · Cited by 401
Fisher, D. A., Maple, J. T., Ben-Menachem, T., Cash, B. D., Decker, G. A., Early, D. S., Evans, J. A., Fanelli, R. D., Fukami, N., Hwang, J. H., et al. (2011) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2011.07.025 · Cited by 324
Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse
Gisbert, J. P., Bermejo, F., Pérez-Calle, J.-L., Taxonera, C., Vera, I., McNicholl, A. G., Algaba, A., López, P., López-Palacios, N., Calvo, M., et al. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20933 · Cited by 315
High prevalence of NSAID enteropathy as shown by a simple faecal test
Tibble, J. A., Sigthorsson, G., Foster, R., Scott, D., Fagerhol, M. K., Roseth, A., & Bjarnason, I. (1999) · Gut · doi:10.1136/gut.45.3.362 · Cited by 307
Meta-analysis: Fecal Calprotectin for Assessment of Inflammatory Bowel Disease Activity
Lin, J.-F., Chen, J.-M., Zuo, J.-H., Yu, A., Xiao, Z.-J., Deng, F.-H., Nie, B., & Jiang, B. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000057 · Cited by 296
Role of faecal calprotectin as non-invasive marker of intestinal inflammation
Costa, F., Mumolo, M. G., Bellini, M., Romano, M. R., Ceccarelli, L., Arpe, P., Sterpi, C., Marchi, S., & Maltinti, G. (2003) · Digestive and Liver Disease · doi:10.1016/s1590-8658(03)00381-5 · Cited by 289
Waugh, N., Cummins, E., Royle, P., Kandala, N.-B., Shyangdan, D., Arasaradnam, R., Clar, C., & Johnston, R. (2013) · Health Technology Assessment · doi:10.3310/hta17550 · Cited by 286
Wright, E. K., Kamm, M. A., De Cruz, P., Hamilton, A. L., Ritchie, K. J., Krejany, E. O., Leach, S., Gorelik, A., Liew, D., Prideaux, L., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.01.026 · Cited by 280
Mao, R., Xiao, Y.-L., Gao, X., Chen, B.-L., He, Y., Yang, L., Hu, P.-J., & Chen, M.-H. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22861 · Cited by 280
Gisbert, J. P., & McNicholl, A. G. (2009) · Digestive and Liver Disease · doi:10.1016/j.dld.2008.05.008 · Cited by 238
Henderson, P., Anderson, N. H., & Wilson, D. C. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.131 · Cited by 234
Improved assay for fecal calprotectin
Tøn, H., Brandsnes, Ø., Dale, S., Holtlund, J., Skuibina, E., Schjønsby, H., & Johne, B. (2000) · Clinica Chimica Acta · doi:10.1016/s0009-8981(99)00206-5 · Cited by 226
Bowel Inflammation as Measured by Fecal Calprotectin
Poullis, A., Foster, R., Shetty, A., Fagerhol, M. K., & Mendall, M. A. (2004) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-03-0160 · Cited by 223
Carroccio, A., Iacono, G., Cottone, M., Di Prima, L., Cartabellotta, F., Cavataio, F., Scalici, C., Montalto, G., Di Fede, G., Rini, G., et al. (2003) · Clinical Chemistry · doi:10.1373/49.6.861 · Cited by 221
Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic disease
D’Incà, R., Dal Pont, E., Di Leo, V., Ferronato, A., Fries, W., Vettorato, M. G., Martines, D., & Sturniolo, G. C. (2007) · International Journal of Colorectal Disease · doi:10.1007/s00384-006-0159-9 · Cited by 215
Kaiser, T., Langhorst, J., Wittkowski, H., Becker, K., Friedrich, A. W., Rueffer, A., Dobos, G. J., Roth, J., & Foell, D. (2007) · Gut · doi:10.1136/gut.2006.113431 · Cited by 212
Lasson, A., Stotzer, P.-O., Öhman, L., Isaksson, S., Sapnara, M., & Strid, H. (2014) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2014.06.002 · Cited by 211
Can Calprotectin Predict Relapse Risk in Inflammatory Bowel Disease?
D'Incà, R., Dal Pont, E., Di Leo, V., Benazzato, L., Martinato, M., Lamboglia, F., Oliva, L., & Carlo Sturniolo, G. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01870.x · Cited by 211
Vos, M. D., Louis, E. J., Jahnsen, J., Vandervoort, J. G. P., Noman, M., Dewit, O., DʼHaens, G. R., Franchimont, D., Baert, F. J., Torp, R. A., et al. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e31829b2a37 · Cited by 202
Faecal calprotectin: a marker of inflammation throughout the intestinal tract
Summerton, C. B., Longlands, M. G., Wiener, K., & Shreeve, D. R. (2002) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200208000-00005 · Cited by 187
Mowat, C., Digby, J., Strachan, J. A., Wilson, R., Carey, F. A., Fraser, C. G., & Steele, R. J. C. (2016) · Gut · doi:10.1136/gutjnl-2015-309579 · Cited by 180
Tibble, J., Sigthorsson, G., Foster, R., Sherwood, R., Fagerhol, M., & Bjarnason, I. (2001) · Gut · doi:10.1136/gut.49.3.402 · Cited by 174
Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis?
García-Sánchez, V., Iglesias-Flores, E., González, R., Gisbert, J. P., Gallardo-Valverde, J. M., González-Galilea, Á., Naranjo-Rodríguez, A., de Dios-Vega, J. F., Muntané, J., & Gómez-Camacho, F. (2010) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2009.09.008 · Cited by 163
What is the peak age for onset of IBD?
Johnston, R. D., & Logan, R. F. A. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20545 · Cited by 158
An update of the S100 nomenclature
Marenholz, I., Lovering, R. C., & Heizmann, C. W. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.07.013 · Cited by 157
Sidler, M. A., Leach, S. T., & Day, A. S. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20336 · Cited by 154
Saverymuttu, S. H., Peters, A. M., Lavender, J. P., Pepys, M. B., Hodgson, H. J. F., & CHADWICK, V. S. (1983) · Gastroenterology · doi:10.1016/s0016-5085(83)80015-8 · Cited by 154
Faecal Calprotectin: A Novel Test for the Diagnosis of Colorectal Cancer?
Røseth, A. G., Kristinsson, J. A., Fagerhol, M. K., Schjønsby, H., Aadland, E., Nygaard, K., & Roald, B. (1993) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529309098312 · Cited by 154
Regueiro, M. D., Velayos, F. S., Greer, J. B., Bougatsos, C., Chou, R., Sultan, S., & Singh, S. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.10.039 · Cited by 147
Peterson, C. G., Eklund, E., Taha, Y., Raab, Y., & Carlson, M. (2002) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05837.x · Cited by 137
Weinstein-Nakar, I., Focht, G., Church, P. C., Walters, T. D., Abitbol, G., Anupindi, S. A., Berteloot, L., Hulst, J. M., Ruemmele, F. M., Lemberg, D. A., et al. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.01.024 · Cited by 135
Gisbert, J. P., McNicholl, A. G., & Gomollón, F. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20920 · Cited by 132
Nickel Sequestration by the Host-Defense Protein Human Calprotectin
Nakashige, T. G., Zygiel, E. M., Drennan, C. L., & Nolan, E. M. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b01212 · Cited by 125
Fecal calprotectin in diagnosis and clinical assessment of inflammatory bowel disease
Sipponen, T., & Kolho, K.-L. (2015) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2014.987809 · Cited by 125
Kallel, L., Ayadi, I., Matri, S., Fekih, M., Mahmoud, N. B., Feki, M., Karoui, S., Zouari, B., Boubaker, J., Kaabachi, N., et al. (2010) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32832bab49 · Cited by 124
Between-assay variability of faecal calprotectin enzyme-linked immunosorbent assay kits
Whitehead, S. J., French, J., Brookes, M., Ford, C., & Gama, R. M. (2012) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2012.011272 · Cited by 121
Takashima, S., Kato, J., Hiraoka, S., Nakarai, A., Takei, D., Inokuchi, T., Sugihara, Y., Takahara, M., Harada, K., Okada, H., et al. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.66 · Cited by 117
Age-Dependent Variations in Fecal Calprotectin Concentrations in Children
Rugtveit, J., & Fagerhol, M. K. (2002) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200203000-00022 · Cited by 111
High faecal calprotectin concentrations in newborn infants
Campeotto, F., Butel, M. J., Kalach, N., Derrieux, S., Aubert-Jacquin, C., Barbot, L., Francoual, C., Dupont, C., & Kapel, N. (2004) · Archives of Disease in Childhood - Fetal and Neonatal Edition · doi:10.1136/adc.2002.022368 · Cited by 107
Age-related faecal calprotectin, lactoferrin and tumour M2-PK concentrations in healthy volunteers
Joshi, S., Lewis, S. J., Creanor, S., & Ayling, R. M. (2010) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1258/acb.2009.009061 · Cited by 106
High Faecal Calprotectin Levels in Healthy, Exclusively Breast-Fed Infants
Savino, F., Castagno, E., Calabrese, R., Viola, S., Oggero, R., & MINIERO, R. (2009) · Neonatology · doi:10.1159/000255161 · Cited by 101
Fecal M2-pyruvate kinase (M2-PK): A novel marker of intestinal inflammation
Chung‐Faye, G., Hayee, B., Maestranzi, S., Donaldson, N., Forgács, I., & Sherwood, R. A. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20214 · Cited by 101
Faecal Calprotectin in Term and Preterm Neonates
Kapel, N., Campeotto, F., Kalach, N., Baldassarre, M. E., Butel, M., & Dupont, C. M. (2010) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3181e2ad72 · Cited by 98
Koulaouzidis, A., Douglas, S., Rogers, M. A., Arnott, I. D., & Plevris, J. N. (2011) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2011.551835 · Cited by 98
High Within-day Variability of Fecal Calprotectin Levels in Patients with Active Ulcerative Colitis
Calafat, M., Cabré, E., Mañosa, M., Lobatón, T., Marín, L., & Domènech, E. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000349 · Cited by 96
Κώστας, Α., Siakavellas, S. I., Kosmidis, C., Takou, A., Nikou, J., Maropoulos, G., Vlachogiannakos, J., Papatheodoridis, G., Papaconstantinou, I. G., & Bamias, G. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i41.7387 · Cited by 88
Poullis, A., Foster, R., & Mendall, M. A. (2003) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200305000-00021 · Cited by 82
Hoff, G. S., Grotmol, T., Thiis‐Evensen, E., Bretthauer, M., Gondal, G., & Vatn, M. H. (2004) · Gut · doi:10.1136/gut.2004.039032 · Cited by 80
Qiu, Y., Mao, R., Chen, B.-L., He, Y., Zeng, Z.-R., Xue, L., Song, X.-M., Li, Z.-P., & Chen, M. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000262 · Cited by 77
Mak, J. W. Y., Buisson, A., Andersen, M. J., Lei, D. K., Pekow, J. R., Cohen, R. D., Kahn, S. A., Pereira, B., & Rubin, D. T. (2018) · Digestive Diseases and Sciences · doi:10.1007/s10620-018-4980-0 · Cited by 76
Burns, E. A., & Leventhal, E. A. (2000) · Cancer Control · doi:10.1177/107327480000700603 · Cited by 75
Age-related decline in rectal mucosal lymphocytes and mast cells
Dunlop, S. P., Jenkins, D., & Spiller, R. C. (2004) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200410000-00010 · Cited by 74
Hestvik, E., Tumwine, J. K., Tylleskar, T., Grahnquist, L., Ndeezi, G., Kaddu-Mulindwa, D. H., Aksnes, L., & Olafsdottir, E. (2011) · BMC Pediatrics · doi:10.1186/1471-2431-11-9 · Cited by 71
Fecal Calprotectin Is Not Affected by Pregnancy
Julsgaard, M., Hvas, C. L., Gearry, R. B., Vestergaard, T., Fallingborg, J., Svenningsen, L., Kjeldsen, J., Sparrow, M., Wildt, S., Kelsen, J., et al. (2017) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000001136 · Cited by 70
Prospective Evaluation of Fecal Calprotectin As A Screening Biomarker for Colorectal Neoplasia
Limburg, P. J., Devens, M. E., Harrington, J. J., Diehl, N. N., Mahoney, D. W., & Ahlquist, D. A. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07630.x · Cited by 70
Mooiweer, E., Fidder, H. H., Siersema, P. D., Laheij, R. J. F., & Oldenburg, B. (2013) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000438428.30800.a6 · Cited by 68
Yamamoto, T., Shimoyama, T., Bamba, T., & Matsumoto, K. (2015) · The American Journal of Gastroenterology · doi:10.1038/ajg.2015.129 · Cited by 65
Inokuchi, T., Kato, J., Hiraoka, S., Takashima, S., Nakarai, A., Takei, D., Sugihara, Y., Takahara, M., Kawano, S., Harada, K., et al. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000728 · Cited by 65
Faecal calprotectin in patients with suspected colorectal cancer: a diagnostic accuracy study
Turvill, J. L., Aghahoseini, A., Sivarajasingham, N. S., Abbas, K., Choudhry, M., Polyzois, K., Lasithiotakis, K., Volanaki, D., Kim, B., Langlands, F. E., et al. (2016) · British Journal of General Practice · doi:10.3399/bjgp16x685645 · Cited by 61
Faecal Elastase Reflects Disease Activity in Active Ulcerative Colitis
Adeyemi, E. O., & Hodgson, H. J. F. (1992) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529209165434 · Cited by 59
Fecal Calprotectin in Healthy Term and Preterm Infants
Nissen, A. C., van Gils, C. E., Menheere, P. P. C. A., den Neucker, A. M. V., van der Hoeven, M. A. H. B. M., & Forget, P. (2003) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200401000-00025 · Cited by 58
Comparison of the different kinds of feeding on the level of fecal calprotectin
Li, F., Ma, J., Geng, S., Wang, J., Ren, F., & Sheng, X. (2014) · Early Human Development · doi:10.1016/j.earlhumdev.2014.06.005 · Cited by 53
A prospective evaluation of the predictive value of faecal calprotectin in quiescent Crohn's disease
Naismith, G., Smith, L., Barry, S., Munro, J. I., Laird, S., Rankin, K., Morris, A. J., Winter, J., & Gaya, D. R. (2014) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2014.01.029 · Cited by 52
Kristensen, V. A., Malmstrøm, G. H., Skar, V., Røseth, A. G., & Moum, B. A. (2015) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2015.1117650 · Cited by 51
Kristensen, V. A., Røseth, A. G., Ahmad, T., Skar, V., & Moum, B. A. (2017) · Gastroenterology Research and Practice · doi:10.1155/2017/2098293 · Cited by 50
Fecal Calprotectin in Healthy Children Aged 1-4 Years
Zhu, Q., Li, F., Wang, J., Shen, L., & Sheng, X. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150725 · Cited by 49
Jeffery, J., Lewis, S. J., & Ayling, R. M. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20946 · Cited by 48
Uppara, M., Adaba, F., Askari, A., Clark, S. K., Hanna, G. B., Athanasiou, T., & Faiz, O. D. (2015) · World Journal of Surgical Oncology · doi:10.1186/s12957-015-0446-4 · Cited by 47
Diagnostic accuracy of fecal lactoferrin for inflammatory bowel disease: a meta-analysis.
Wang, Y., Pei, F., Wang, X., Sun, Z., Hu, C., & Dou, H. (2015) · PubMed · Cited by 45
Holtman, G. A., van Leeuwen, Y., Kollen, B. J., Norbruis, O. F., Escher, J. C., Kindermann, A., de Rijke, Y. B., van Rheenen, P. F., & Berger, M. Y. (2016) · The Annals of Family Medicine · doi:10.1370/afm.1949 · Cited by 44
Bello, C., Røseth, A. G., Guardiola, J., Reenaers, C., Ruiz‐Cerulla, A., Kemseke, C. V., Aràjol, C., Reinhard, C., Seidel, L., & Louis, E. J. (2017) · Digestive and Liver Disease · doi:10.1016/j.dld.2017.05.009 · Cited by 43
Dai, C., Jiang, M., Sun, M., & Cao, Q. (2018) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14121 · Cited by 36
Can chronic gastritis cause an increase in fecal calprotectin concentrations?
Montalto, M., Gallo, A., Ianiro, G., Santoro, L., D’Onofrio, F., Ricci, R., Cammarota, G., Covino, M., Vastola, M., Gasbarrini, A., et al. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i27.3406 · Cited by 35
The hetero‐oligomeric complex of the S100A8/S100A9 protein is extremely protease resistant
Nacken, W., & Kerkhoff, C. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.09.060 · Cited by 34
The Value of Fecal Markers in Predicting Relapse in Inflammatory Bowel Diseases
Galgut, B. J., Lemberg, D. A., Day, A. S., & Leach, S. T. (2018) · Frontiers in Pediatrics · doi:10.3389/fped.2017.00292 · Cited by 32
Immune activation during infancy in healthy humans
Cummins, A. G., Eglinton, B. A., Gonzalez, A., & Roberton, D. (1994) · Journal of Clinical Immunology · doi:10.1007/bf01541343 · Cited by 29
Fecal Lysozyme in Assessment of Disease Activity in Inflammatory Bowel Disease
Veer, A. V. D. S., Brouwer, J., Biemond, I., Bohbouth, G. E., Verspaget, H. W., & Lamers, C. B. H. W. (1998) · Digestive Diseases and Sciences · doi:10.1023/a:1018823426917 · Cited by 25
Luley, K. B., NOACK, F., Lehnert, H., & Homann, N. (2011) · International Journal of Colorectal Disease · doi:10.1007/s00384-011-1165-0 · Cited by 24
Whitehead, S. J., Ford, C., Gama, R. M., Ali, A., McKaig, B. C., Waldron, J. L., Steed, H., & Brookes, M. (2017) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2017-204340 · Cited by 21
Faecal calprotectin as a marker for oesophago-gastric cancer
Vincent, Z., Hornby, S. T., Ball, S., Sanders, G., & Ayling, R. M. (2015) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563215578191 · Cited by 17
Are we exposing patients with a mildly elevated faecal calprotectin to unnecessary investigations?
Seenan, J. P., Thomson, F., Rankin, K., Smith, K. A., & Gaya, D. R. (2014) · Frontline Gastroenterology · doi:10.1136/flgastro-2014-100467 · Cited by 13
Cited by
Probiotics for Constipation in Parkinson Disease: A Randomized Placebo-Controlled Study
Tan, A. H., Lim, S.-Y., Chong, K. K., A Manap, M. A. A., Hor, J. W., Lim, J. L., Low, S. C., Chong, C. W., Mahadeva, S., & Lang, A. E. (2021) · Neurology · doi:10.1212/wnl.0000000000010998 · Cited by 226
Chen, Y., Ouyang, Y., Li, Z., Wang, X., & Ma, J. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188891 · Cited by 165
Clostridioides difficile ferrosome organelles combat nutritional immunity
Pi, H., Sun, R., McBride, J. R., Kruse, A. R. S., Gibson-Corley, K. N., Krystofiak, E. S., Nicholson, M. R., Spraggins, J. M., Zhou, Q., & Skaar, E. P. (2023) · Nature · doi:10.1038/s41586-023-06719-9 · Cited by 54
Wasiak, J., & Gawlik-Kotelnicka, O. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114459 · Cited by 47
The Immune Protein Calprotectin Impacts Clostridioides difficile Metabolism through Zinc Limitation
Lopez, C. A., Beavers, W. N., Weiss, A., Knippel, R. J., Zackular, J. P., Chazin, W., & Skaar, E. P. (2019) · mBio · doi:10.1128/mbio.02289-19 · Cited by 42
Metadata
- Venue
- Advances in Clinical Chemistry
- Publisher
- Elsevier
- Published
- 2018
- Volume
- 87
- Pages
- 161-190
- ISSN
- 0065-2423 (ISSN-L)
- OpenAlex
- W4211178974
- Cited by
- 180
- References
- 103
- FWCI
- 44.82
- Type
- book chapter
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.